Cancer Research

Cancer is the leading cause of death in Australia. Further, one in two Australian men and one in three Australian women will be diagnosed with cancer by the age of 85. The Ingham Institute has a broad portfolio of cancer research programs that encompass basic science, clinical, psychosocial and health services research. These programs ultimately benefit the treatment and care of cancer patients and their carers.

Our flagship cancer research program is the MRI-Linac, which works to combine an MRI scanner with a Linear Accelerator for research into cancer therapy and treatment. An Australian-first at the Ingham Institute, the new technology will help to improve the standard of radiotherapy treatment for cancer by enabling improved monitoring of tumours during a radiation therapy session, which will ensure more effective treatment for the patient. At present, around 50 per cent of cancer patients undergo radiotherapy treatment or cancer.

Ingham Institute cancer researchers are also conducting vital work to help detect and also stop the spread of cancers via Circulating Tumour Cells (CTC) research. CTC research at the Ingham Institute uses a blood sample as a liquid biopsy which identifies cancer cells in the blood so that they can be isolated and their genetic make-up studied. This approach helps to determine why and how certain cancers spread to develop a targeted and personalised treatment for each individual patient.

Click here for our Cancer Research Brochure. 

  1. CCORE
  2. Cancer Pathology
  3. Clinical Cancer Registry
  4. Gastro-Intestinal Viral Oncology Group
  5. Haematology Group
  6. MRI-Linac
  7. Medical Physics
  8. Oncology Clinical Trials Unit
  9. Palliative Care Clinical Trials
  10. Pancreatic Research Group
  11. Psycho-Oncology Research Group
  12. Translational Cancer Research Unit